THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC
BSE656.00-6 (-0.91 %)
PREV CLOSE ( ) 662.00
OPEN PRICE ( ) 660.10
BID PRICE (QTY) 654.60 (8)
OFFER PRICE (QTY) 656.55 (8)
VOLUME 3790
TODAY'S LOW / HIGH ( )648.95 666.20
52 WK LOW / HIGH ( )432.05 722
NSE655.10-4.7 (-0.71 %)
PREV CLOSE( ) 659.80
OPEN PRICE ( ) 660.90
BID PRICE (QTY) 655.05 (1)
OFFER PRICE (QTY) 655.90 (10)
VOLUME 40002
TODAY'S LOW / HIGH( ) 649.10 663.95
52 WK LOW / HIGH ( )433 722.65
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.